Radiant Sage enhances Core-Lab-in-a-Box software

Tuesday, July 26, 2011 12:20 PM

Radiant Sage, a provider of on-demand Clinical Trial Image Management Solutions, has enhanced its flagship Core-Lab-in-a-Box product. Specifically designed for imaging clinical trials, this Software-as-a-Service (SaaS) image management solution enables rapid trial starts and increases overall efficiency of the collection, distribution and processing of images.

Core-Lab-in-a-Box is a purpose-built clinical trial image management software package that provides sponsors with the key functionality of an imaging core lab without the associated expense and risk. It facilitates study execution, regulatory compliance and exploratory research. Furthermore, offered via a SaaS delivery model, Core-Lab-in-a-Box enables sponsors to have a trial up and running in just weeks.

Some of the new features and functionality of Core-Lab-in-a-Box include: Workflow Engine; integrated eCRF (electronic case report forms); web-based Trial Administration and Configuration; upfront QA/QC; Meta Data Standardization Support; Single Sign-on; direct access to images utilizing DICOM protocols; multilingual support and additional export features.

Share:          
CLINICAL TRIAL RESOURCES

Search:

NEWS ONLINE ARCHIVE

Browse by:

CWWeekly

September 30

Novartis-Walgreens pilot study blurring the line between retail pharmacy, investigative site

CISCRP to launch traveling science museum exhibit to demystify clinical trial participation

Already a subscriber?
Log in to your digital subscription.

Subscribe to CWWeekly.

The CenterWatch Monthly

October

New growth and decline in Asia clinical trials
South Korea, Japan, China see big growth in 1572s, while India posts huge drop

Harnessing Big Data to transform clinical trials
From protocol to patient recruiting, data analytics can yield valuable insights

Already a subscriber?
Log in to your digital subscription.

Purchase the October issue.

Subscribe to
The CenterWatch Monthly.

The CenterWatch Monthly

September

Sponsors look to collaborate on comparator drugs
Co-therapies, comparators are in 60% of studies, cost $25m per company a year

Early adopters implement risk-based monitoring pilot programs
Experiments aim to offer long-term solutions, despite short-term uncertainties

Already a subscriber?
Log in to your digital subscription.

Purchase the September issue.

Subscribe to
The CenterWatch Monthly.

JobWatch centerwatch.com/jobwatch

Featured Jobs